Deepak Chadha is Chief Research & Dev. Officer at Brickell Biotech, Inc. (BBI). They have made 1 open-market trade across 1 company since 2020, most recently 2023-09-01.
CIK 0001784380
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $13K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBI | BUY | 2021-05-18 | 2021-05-19 | $0.83 | $13K | -2.2% | -6.8% | -30.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.